Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: April 26, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 064008

« Back to Dashboard

NDA 064008 describes PENTACEF, which is a drug marketed by Glaxosmithkline and is included in three NDAs. Additional details are available on the PENTACEF profile page.

The generic ingredient in PENTACEF is ceftazidime. There are seventeen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the ceftazidime profile page.

Summary for 064008

Tradename:	PENTACEF
Applicant:	Glaxosmithkline
Ingredient:	ceftazidime
Patents:	0
Therapeutic Class:	Antibacterials
Formulation / Manufacturing:	see details

Medical Subject Heading (MeSH) Categories for 064008

Anti-Bacterial Agents

Profile for product number 001

Active Rx/OTC/Discontinued:	DISCN	Dosage:	INJECTABLE;INJECTION			Strength	6GM/VIAL
Approval Date:	Mar 31, 1992	TE:		RLD:	No

Profile for product number 002

Active Rx/OTC/Discontinued:	DISCN	Dosage:	INJECTABLE;INJECTION			Strength	10GM/VIAL
Approval Date:	Mar 31, 1992	TE:		RLD:	No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance

Argus Health

Federal Trade Commission

Fish and Richardson

US Army

Cipla

QuintilesIMS

Cantor Fitzgerald

Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.